1. Home
  2. AGM vs ZYME Comparison

AGM vs ZYME Comparison

Compare AGM & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federal Agricultural Mortgage Corporation

AGM

Federal Agricultural Mortgage Corporation

HOLD

Current Price

$182.33

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$25.70

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGM
ZYME
Founded
1987
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
AGM
ZYME
Price
$182.33
$25.70
Analyst Decision
Buy
Strong Buy
Analyst Count
1
9
Target Price
$219.00
$29.50
AVG Volume (30 Days)
83.2K
1.7M
Earning Date
11-03-2025
11-06-2025
Dividend Yield
3.29%
N/A
EPS Growth
12.85
N/A
EPS
17.55
N/A
Revenue
$377,946,000.00
$134,481,000.00
Revenue This Year
$14.80
$64.45
Revenue Next Year
$9.98
$67.04
P/E Ratio
$10.38
N/A
Revenue Growth
8.81
116.21
52 Week Low
$155.00
$9.03
52 Week High
$216.35
$28.49

Technical Indicators

Market Signals
Indicator
AGM
ZYME
Relative Strength Index (RSI) 69.06 60.22
Support Level $173.59 $24.79
Resistance Level $186.64 $27.49
Average True Range (ATR) 4.35 1.27
MACD 1.31 -0.27
Stochastic Oscillator 85.65 36.74

Price Performance

Historical Comparison
AGM
ZYME

About AGM Federal Agricultural Mortgage Corporation

Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: